Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD



Rating:

Share or cite this content

Citations should be made in the following way:
H. Whittaker (London, United Kingdom), A. Rubino (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), T. Morris (Luton, United Kingdom), P. Varghese (Gaithersburg, MD, United States of America), Y. Xu (Luton, United Kingdom), E. De Nigris (Cambridge, United Kingdom), J. Quint (London, United Kingdom). Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK. 3826

Member's Comments

No comment yet.

Related content which might interest you: In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality Source: International Congress 2015 – COPD: interesting notes Year: 2015 β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Are COPD exacerbations associated with the severity of the disease? Source: Eur Respir J 2005; 26: Suppl. 49, 300s Year: 2005 Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Trends in the lifetime risk of COPD exacerbation requiring hospitalisation Source: Eur Respir J 2013; 42: 964-971 Year: 2013 Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Variability in exacerbation frequency in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 264s Year: 2002 Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Exacerbation types by COPD severity; risk of hospitalisation by patients not seeking treatment Source: Eur Respir J 2003; 22: Suppl. 45, 353s Year: 2003 Predictors of mortality in COPD patients after hospitalization due to an exacerbation Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Under reporting acute exacerbation in patient with COPD: incidence and predictors? Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006 Budesonide is not associated with increased risk of pneumonia in COPD patients Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Early occurrence of any COPD exacerbation predicts further higher risk of moderate/severe exacerbations regardless of recording tool: the FLAME study Source: International Congress 2017 – Management of COPD Year: 2017 Prevalence of comorbidity in patients with COPD and its effect on mortality Source: Annual Congress 2003 - Staging and outcome in COPD Year: 2003 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Factors associated with exacerbations in US patients with COPD Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 Risk factors for mortality in patients with COPD exacerbation Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 COPD mortality after severe exacerbations Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020